Vaccines exist against the plague caused by Yersinia pestis
the verdict
SUPPORTED
the evidence backs this
confidence 86/100
Multiple scientific studies and historical data confirm that effective vaccines and immunization strategies exist against the plague caused by Yersinia pestis.
Evidence for · 12
Development of In Vitro Correlate Assays of Immunity to Infection with Yersinia pestis
2007 · cited by 68
Discusses the development of surrogate immunity assays and vaccine candidates against Yersinia pestis.
See more details
More for · 11
Development of Yersinia pestis F1 antigen-loaded microspheres vaccine against plague
2014 · cited by 28
Evaluates an F1 antigen-loaded microsphere vaccine offering protection against plague in mice.
Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague
2019 · cited by 20
Examines rF1-V subunit vaccine formulations and their efficacy against pneumonic plague.
Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.
2019 · cited by 20
Demonstrates that live-attenuated vaccines protect against bubonic and pneumonic plague.
Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis
2019 · cited by 13
Presents a multiple-antigen protein fusion vaccine candidate conferring protection against Yersinia pestis.
Rapid Induction of Protective Immunity against Pneumonic Plague by Yersinia pestis Polymeric F1 and LcrV Antigens
2023 · cited by 9
Shows that polymeric F1 and LcrV antigens rapidly induce protective immunity against pneumonic plague.
Live attenuated vaccines and layered defense strategies to combat infections caused by nonencapsulated Yersinia pestis
2023 · cited by 6
Analyzes live attenuated vaccines and layered defense strategies against nonencapsulated Yersinia pestis.
Serologic Markers for Long-Term Immunity in Humans Vaccinated with Live Yersinia pestis EV NIIEG
2012 · cited by 4
Describes the use of the live Yersinia pestis EV NIIEG vaccine for prophylaxis against plague in humans.
Multifaceted Approach to Assessing and Forecasting the Immune Response to Vaccination in Population Immunized against Plague
2024 · cited by 2
Evaluates post-vaccination immunity and group responsiveness in populations immunized against plague.
An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.
2026 · cited by 1
Presents a novel adenoviral vectored vaccine protecting mice against aerosol challenge with Yersinia pestis.
Experimental approach to immunomodulatory drug selection to improve plague vaccination efficacy
2025 · cited by 0
Tests immunization schemes involving the live plague vaccine strain Yersinia pestis EV line NIIEG.
Introduction
2002 · cited by 0
Notes that vaccines and antibiotics presently enable health workers to limit plague outbreaks and infections.